Why not take a break from the fire hose of Twitter and RSS and check out our weekly roundup of essential writing from around the web about technology, culture, media, and the future? Sure, it's one more thing you can feel guilty about sitting in your Instapaper queue, but it's better than pulling in vain on your Twitter list again. Stephen S. Hall examines the controversy over Zohydro, a new FDA-approved painkiller, and America's prescription-painkiller epidemic. New York: Stephen S. Hall - How Much Does It Hurt?
via Tech News Headlines - Yahoo News http://ift.tt/TYUqiB
Brak komentarzy:
Prześlij komentarz